Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Top Stories

Posted By Gbaf News

Posted on November 21, 2014

GOVT WANTS MORE CLINICAL TRIAL RESULTS MADE PUBLIC

LAURAN NEERGAARD,AP Medical Writer

WASHINGTON (AP) — The government proposed new rules Wednesday to make it easier for doctors and patients to learn if clinical trials of treatments worked or not.

Thousands of Americans participate in clinical trials every year, testing new treatments, comparing old ones or helping to uncover general knowledge about health. Many of the studies are reported in scientific journals and trumpeted in the news. But results aren’t always made public, especially studies that fail.

National Institutes of Health Director Francis Collins says that’s not acceptable. Under the new proposals, all clinical trials funded by NIH would have to reveal summaries of their results on a public database: www.clinicaltrials.gov . So would certain other studies under an expansion of Food and Drug Administration rules.

The proposals are open for public comment through Feb. 19.

Recommended for you

  • Insurance & Takaful Awards 2025 - Call for Entries

  • Dubai Real Estate Market 2025: A Promising Horizon

  • James Dondero: A Life of Vision, Philanthropy, and Global Impact